- Home
- ADV vs QURE Comparison
ADV vs QURE Comparison
Compare ADV & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADV
- QURE
- Stock Information
- Founded
- ADV 1987
- QURE 1998
- Country
- ADV United States
- QURE Netherlands
- Employees
- ADV N/A
- QURE N/A
- Industry
- ADV Business Services
- QURE Biotechnology: Pharmaceutical Preparations
- Sector
- ADV Consumer Discretionary
- QURE Health Care
- Exchange
- ADV Nasdaq
- QURE Nasdaq
- Market Cap
- ADV 875.7M
- QURE 711.1M
- IPO Year
- ADV N/A
- QURE 2007
- Fundamental
- Price
- ADV $2.15
- QURE $12.23
- Analyst Decision
- ADV
- QURE Buy
- Analyst Count
- ADV 0
- QURE 9
- Target Price
- ADV N/A
- QURE $38.25
- AVG Volume (30 Days)
- ADV 364.7K
- QURE 956.9K
- Earning Date
- ADV 03-07-2025
- QURE 02-27-2025
- Dividend Yield
- ADV N/A
- QURE N/A
- EPS Growth
- ADV N/A
- QURE N/A
- EPS
- ADV N/A
- QURE N/A
- Revenue
- ADV $3,566,324,000.00
- QURE $27,119,000.00
- Revenue This Year
- ADV N/A
- QURE $33.81
- Revenue Next Year
- ADV $2.02
- QURE $247.07
- P/E Ratio
- ADV N/A
- QURE N/A
- Revenue Growth
- ADV N/A
- QURE 71.17
- 52 Week Low
- ADV $2.04
- QURE $3.73
- 52 Week High
- ADV $4.95
- QURE $19.18
- Technical
- Relative Strength Index (RSI)
- ADV 31.09
- QURE 45.15
- Support Level
- ADV $2.26
- QURE $10.04
- Resistance Level
- ADV $2.69
- QURE $13.37
- Average True Range (ATR)
- ADV 0.15
- QURE 1.14
- MACD
- ADV -0.03
- QURE 0.02
- Stochastic Oscillator
- ADV 16.31
- QURE 50.00
About ADV Advantage Solutions Inc.
Advantage Solutions Inc is the provider of outsourced sales and marketing solutions to consumer goods companies and retailers. It has a technology-enabled platform of sales and marketing services like headquarter sales, retail merchandising, in-store sampling, digital commerce, and shopper marketing. For brands and retailers of all sizes, the firm helps to get the right products on the shelf and into the hands of consumers. The company helps its clients to sell more while spending less. Advantage has offices throughout North America and strategic investments in select markets throughout Africa, Asia, Australia, and Europe through which it services the global needs of multinational, regional, and local manufacturers. Its services are provided across two segments sales and marketing.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.